Many patients with interleukin 28B genotypes associated with response to therapy are ineligible for treatment because of comorbidities.
Many patients with interleukin 28B genotypes associated with response to therapy are ineligible for treatment because of comorbidities. Clin Gastroenterol Hepatol. 2014 Feb; 12(2):327-333.e1.